LearnGlossaryMarketStocksSuperinvestorsSign in

ANGO

AngioDynamics, Inc.

Healthcare · $640M market cap

Verdict

We can't put a fair value on ANGO right now. It lost money in at least 2 of its last 3 years, so one year of cash flow isn't a reliable base to value it on.

Business quality

0 of 5 clear the 10% bar. What are the Big Five?

Earnings per share growth6.5% a year✗
Equity per share growth-4.2% a year✗
Sales growth2.7% a year✗
Free cash flow growth4.1% a year✗
Return on invested capital-40.1%✗

Follow ANGO

Track it on your watchlist and see the full analysis. Free.

Create a free account

Superinvestors

1 of the investors we track holds ANGO. Who we track

First Eagle Investment Management

First Eagle Investment Management · as of Q2 2026

$3.6M

276,435 shares

About AngioDynamics, Inc.

AngioDynamics, Inc. specializes in the development, manufacturing, and commercialization of a diverse array of medical, surgical, and diagnostic instruments. These products are utilized by healthcare professionals to address conditions such as peripheral vascular disease, facilitate vascular access, and support various oncology and surgical interventions, serving both domestic and international markets. The…

Medical - Instruments & Supplies

Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works